![](/img/cover-not-exists.png)
A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia
Strati, Paolo, Tong, Wei-Gang, Vitale, Candida, Wierda, William G., O’Brien, Susan, Brown, Jennifer R., Weng, Wen-Kai, Kipps, Thomas, Keating, Michael J., Ferrajoli, AlessandraVolume:
56
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2014.974049
Date:
June, 2015
File:
PDF, 469 KB
english, 2015